JPMorgan Chase & Co. reiterated their underweight rating on shares of Amarin (NASDAQ:AMRN – Free Report) in a report published on Monday morning, Benzinga reports. A number of other analysts have also commented on the company. Jefferies Financial Group lowered Amarin from a buy rating to a hold rating and cut their price target for […]
Amarin (NASDAQ:AMRN – Get Free Report) and Roche (OTCMKTS:RHHBY – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, profitability, earnings, dividends and valuation. Volatility and Risk Amarin has a beta of 1.87, indicating […]
Amarin (NASDAQ:AMRN – Get Free Report) and Roche (OTCMKTS:RHHBY – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, dividends, earnings, valuation and risk. Valuation and Earnings This table compares Amarin and Roche’s top-line […]